CoChat

Cost-utility analysis of telephone-based cognitive behavior therapy in chronic obstructive pulmonary disease (COPD) patients with anxiety and depression comorbidities: an application for willingness to accept concept

Open access
Moayeri, Foruhar, Dunt, David, Hsueh, Ya-Seng (Arthur), Doyle, Colleen · 2019 · Expert Review of Pharmacoeconomics & Outcomes Research

The DOI matches its Crossref record; 43 of the 44 references it cites were found in a registry or an index.

Abstract

Background: This study evaluated the cost-utility of telephone-based cognitive behavioral therapy (TB-CBT) (experimental arm) in comparison with a placebo-befriending (control arm) program in COPD participants with mild to severe depression and/or anxiety. Methods: The decision rule was based on willingness-to-pay if there is an increased unit of effectiveness (a quality-adjusted life year [QALY] gain) and an increase in cost, and willingness-to-accept (WTA) if there is a reduced unit of effectiveness (a QALY loss) and decrease in cost (a cost-saving). Results: TB-CBT group was associated with a reduction in the incremental cost of AUS−$407.3 (p < 0.001, SE:34.1) plus a negative, nonsignificant incremental QALY gain of −0.008 (SE:0.011) per patient compared to control group. The point estimate of the mean incremental cost-utility ratio was AUS$50,284.0 cost saving per QALY sacrificed (the high value associated with small QALY value in the denominator). Ninety-five percent CI was AUS$13,426 cost sacrificed to AUS$32,018 cost gain (lower values associated with larger QALY values in the denominator). If the societal’s minimum (flooring threshold) WTA is AUS$64,000 per QALY forgone, the probability of TB-CBT being cost-effective was 42% Conclusions: This study showed that TB-CBT can be recommended as a cost-saving and preventive approach over usual care plus befriending program. © 2018, © 2018 Informa UK Limited, trading as Taylor & Francis Group.

Overview

Integrity signals

Registry

Crossref · 10.1080/14737167.2019.1536550

Cites

43 of 43 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Citations

Cites

Show all 43 references

Research works printed but not linked: 3

  1. Cafarella PA, 2013, Eur Respir Monogr, 59, 144
  2. Doyle C, 2016, Int J Chron Obstruct Pulmon Dis, 11, 327
  3. Hoffman E, 1993, Wash Univ Law Q, 71, 59

Cited by

See all 15

Metadata

Authors
Moayeri, F., Dunt, D., Hsueh, Y.-S. (., & Doyle, C.
Affiliations
  • The University of Melbourne (AU)
  • Australian Catholic University (AU)
Corresponding author
Moayeri, Foruhar
Venue
Expert Review of Pharmacoeconomics & Outcomes Research
Published
2018-10-19
Volume
19
Issue
3
Pages
331-340
ISSN
  • 1473-7167 (ISSN-L)
  • 1744-8379
OpenAlex
W2896984381
Cited by
15
References
44
Citations by year
2026: 2 · 2023: 4 · 2022: 6 · 2020: 2 · 2019: 1
FWCI
1.14
Type
journal article
Language
en
Open access
Licence
cc-by
Locations
  • Expert Review of Pharmacoeconomics & Outcomes Research (publishedVersion)
  • PubMed (publishedVersion)
  • Research Bank (Australian Catholic University) (submittedVersion)
  • Figshare (submittedVersion, cc-by)
  • Figshare (cc-by)
Funders
  • Beyondblue
  • National Ageing Research Institute (NARI)
Topics
  • Social Sciences › Economics, Econometrics and Finance › Economics and Econometrics › Health Systems, Economic Evaluations, Quality of Life
  • Social Sciences › Psychology › Applied Psychology › Digital Mental Health Interventions
  • Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Chronic Obstructive Pulmonary Disease (COPD) Research
Keywords
chronic obstructive pulmonary disease, depression, anxiety, comorbidities, willingness to accept, cost-utility analysis, cost-effectiveness, quality-adjusted life years
MeSH terms
Aged, Anxiety, Cost-Benefit Analysis, Depression, Female, Humans, Male, Middle Aged, Patient Acceptance of Health Care, Severity of Illness Index, Telephone, Cognitive Behavioral Therapy, Treatment Outcome, Cost Savings, Quality-Adjusted Life Years, Pulmonary Disease, Chronic Obstructive

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Cost-utility analysis of telephone-based cognitive behavior therapy in chronic obstructive pulmonary disease (COPD) patients with anxiety and depression comorbidities: an application for willingness to accept concept. https://app.cochat.ai/papers/10.1080/14737167.2019.1536550
The paper
Moayeri, F., Dunt, D., Hsueh, Y.-S. (., & Doyle, C. (2019). Cost-utility analysis of telephone-based cognitive behavior therapy in chronic obstructive pulmonary disease (COPD) patients with anxiety and depression comorbidities: an application for willingness to accept concept. Expert Review of Pharmacoeconomics & Outcomes Research. https://doi.org/10.1080/14737167.2019.1536550

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.